RIGHT TO BREATHE - Homepage

Everyone should have the right to breathe. You can make an impact on the people who enact change to health plan policies for Bronchial Thermoplasty (BT). Here’s an easy way to reach out to insurance companies and state representatives to let them know why coverage for BT is important to you.

TAKE ACTION

1-2 Million
ADULTS
SUFFER
WITH SEVERE ASTHMA¹

92% of Severe Asthmatics
ARE POORLY CONTROLLED
OR NOT WELL CONTROLLED²

CLINICAL BENEFITS
OF BRONCHIAL THERMOPLASTY

32%
DECREASE

in severe asthma attacks³

84%
DECREASE

in emergency room visits for respiratory related symptoms³

66%
FEWER

asthma-related days lost from work, school, and other activities³

79%
OF PATIENTS

treated with Bronchial Thermoplasty reported significant improvement in their asthma-related quality of life³

The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists.As with any procedure, there are risks, and individual results may vary. The most common adverse event of BT is a temporary worsening of respiratory-related symptoms.

Learn More

About Bronchial Thermoplasty

Hear from Patients about their experience with BT

“The impact BT had for me is quite dramatic. I have overall better asthma control. Having struggled my whole life, almost daily, with severe asthma, so to finally be living a life that is not centered on my asthma control is amazing.” Read More.... -Mark
"I would have BT again in a heartbeat! I still have severe asthma but now that it is in better control it does not hold me back. I am constantly on the go now. I have a career and travel for work and pleasure all the time. ” Read More.... -Krystal
“It has now been over a year since I had BT and I have been doing amazing. I have only been on Prednisone for one 5-day burst when I caught the flu. This is a stark contrast to years prior where I would need Prednisone bursts on a regular basis to treat severe asthma attacks. My health and asthma-related quality of life have improved greatly.” Read More.... -David
“The procedures went pretty smoothly for me. Now it’s been over two years. I am golfing more and better yet, I can walk the courses now! I am missing less work. Haven’t had any ER visits. I’ve only needed one burst of steroids for a severe flare up in the past two years. Before BT, I needed one per month!” Read More.... -Julie

Take Action

to help make a difference

ABOUT BRONCHIAL THERMOPLASTY PATIENT STORIES TAKE ACTION

©2018 Boston Scientific Corporation or its affiliates. All rights reserved. All trademarks are property of their respective owners.
Right to Breathe is a patient advocacy initiative sponsored by Boston Scientific Corporation.

1 Wenzel, Sally. Severe Asthma in Adults. American Journal of Respiratory and Critical Care Medicine. VOL 172 2005. And www.cdc.gov/asthma/most_recent_data.htm

2 Chipps et al. Journal of Allergy and Clinical Immunology August 2017 More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II. Bradley E. Chipps, MD,a Tmirah Haselkorn, PhD,b Brandee Paknis, PharmD,c Benjamin Ortiz, MD,c Eugene R. Bleecker, MD,d Farid Kianifard, PhD,c Aimee J. Foreman, MA,e Stanley J. Szefler, MD,f and Robert S. Zeiger, MD, PhD,g for the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study Group Sacramento, Los Altos, San Francisco, and San Diego, Calif; East Hanover, NJ; Winston-Salem, NC; and Aurora, Colo

3 Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124.

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events: The Alair Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common adverse event of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms. ENDO-551804-AA May 2018

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician. Refer to Prescriptive Information for Indications for Use, Contraindications, Potential Complications and Warnings and Precautions.

ENDO-552203-AA June 2018